Effect of Xanthotoxin on Potentiating Anticonvulsant Activity of Rauwolfia Serpentina in Experimental Animals.

Main Article Content

Vishal S. Adak
Shrikant R. Borate
Rushikesh D. Gopal
Rajkumar V. Shete
Komal S. Yadav
Manish A. Chavan
Sahil M. Burte
Tushar H. Dhanawade
Mrunal M. Karanjkar


The present investigation aimed to evaluate effect of xanthotoxin on potentiating anticonvulsant activity of Rauwolfia serpentina on the chemically induced convulsions in experimental animals and compare the effect of xanthotoxin on anticonvulsant activity of Rauwolfia serpentina with the standard dose of Diazepam on Pentylenetetrazol and Strychnine HCL model. Moreover, brain GABA levels were estimated to investigate the mechanisms underlying the anticonvulsant activity. In this study, results indicate that xanthotoxin (50 and 100 mg/kg, i.p.) significantly potentiated anticonvulsant activity of Rauwolfia serpentina. Similarly, xanthotoxin (100 mg/kg, i.p.) markedly enhanced the anticonvulsant action of Rauwolfia serpentina showed significant and dose-dependent inhibition of PTZ and Strychnine-induced convulsions. Furthermore, addition of xanthotoxin with Rauwolfia serpentina showed significantly increased GABA levels in brain as compared to Rauwolfia serpentina. The parameters observed in PTZ and Strychnine-induced models were seizure latency, duration, and mortality. Combination of xanthotoxin with Rauwolfia serpentina showed significant anticonvulsant activity in experimental animals.

Article Details

How to Cite
Vishal S. Adak, Shrikant R. Borate, Rushikesh D. Gopal, Rajkumar V. Shete, Komal S. Yadav, Manish A. Chavan, Sahil M. Burte, Tushar H. Dhanawade, & Mrunal M. Karanjkar. (2023). Effect of Xanthotoxin on Potentiating Anticonvulsant Activity of Rauwolfia Serpentina in Experimental Animals. Journal of Coastal Life Medicine, 11(2), 1160–1173. Retrieved from https://www.jclmm.com/index.php/journal/article/view/1141


Epilepsy [Internet]. [cited 2023 May 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy

Mattson RH. Efficacy and Adverse Effects of Established and New Antiepileptic Drugs. 1995.

Neeru KS, Sharma Nidhi. Study Of Antiepileptic Activity of Roylea Elegans Wall (Aerial Parts). World Journal of Pharmacy and Pharmaceutical Sciences [Internet]. 2016;5(7):439–53. Available from: www.wjpps.com

Shireen E, Ali W, Akhtar Qureshi S, Binte Ali W, Masroor M, Qureshi SA, et al. Oral Administration of Rauwolfia Serpentina Plant Extract Mitigated Immobilization Stress-Induced Biochemical and Behavioral Deficits in Rats [Internet]. Vol. 42, J.Chem.Soc.Pak. 2020. Available from: https://www.researchgate.net/publication/345315952

Shah SMA, Naqvi SAR, Munir N, Zafar S, Akram M, Nisar J. Antihypertensive and Antihyperlipidemic Activity of Aqueous Methanolic Extract of Rauwolfia Serpentina in Albino Rats. Dose-Response. 2020 Jul 1;18(3).

Charan AA, Prasad S, Singh HK, Prasad SM, Charan A, Charan AI. Antifungal and antibacterial activity of methanolic, ethanolic and acetonic leaf extracts of sarpagandha (Rauwolfia serpentina). J Pharmacogn Phytochem [Internet]. 2017;6(5). Available from: https://www.researchgate.net/publication/325076503

Bilal Azmi M, Akhtar Qureshi S, Pharm Sci PJ, Qureshi SA. Rauwolfia serpentina improves altered glucose and lipid homeostasis in fructose-induced type 2 diabetic mice [Internet]. Vol. 29, Article in Pakistan Journal of Pharmaceutical Sciences. 2016. Available from: https://www.researchgate.net/publication/306393360

Sivaraman T, Sreedevi NS, Meenachisundharam S, Vadivelan R. Neutralizing potential of Rauvolfia serpentina root extract against naja naja venom. Brazilian Journal of Pharmaceutical Sciences. 2020; 56:1–10.

9 Ezeigbo II, Ezeja MI, Madubuike KG, Ifenkwe DC, Ukweni IA, Udeh NE, et al. Antidiarrhoeal activity of leaf methanolic extract of Rauwolfia serpentina. Asian Pac J Trop Biomed. 2012;2(6):430–2.

Charveron M, Assii~ MB, Stenger A, Briley M, Charveron M, Assiik MB, et al. Agonist-Type Activity of Raubasine, A Rauwolfia Serpentina Alkaloid. Vol. 106, European Journal of Pharmacology. 1985.

Purohit M, Pande D, Datta A, Srivastava PS. In Vitro Flowering and High Xanthotoxin in Ammi majus L. Vol. 4, J. Plant Biochemistry & Biotechnology. 1995.

Skalicka-Woźniak K, Zagaja M, Głowniak K, Łuszczki JJ. Purification and anticonvulsant activity of xanthotoxin (8-methoxypsoralen). Cent Eur J Biol. 2014 Jan;9(4):431–6.

Issa MY, Elshal MF, Fathallah N, Abdelkawy MA, Bishr M, Salama O, et al. Potential Anticancer Activity of the Furanocoumarin Derivative Xanthotoxin Isolated from Ammi majus L. Fruits: In Vitro and In Silico Studies. Molecules. 2022 Feb 1;27(3).

Dou C, Chen Y, Ding N, Li N, Jiang H, Zhao C, et al. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis. Osteoporosis International. 2016 Jul 1;27(7):2335–44.

Hindam MO, Sayed RH, Skalicka-Woźniak K, Budzyńska B, EL Sayed NS. Xanthotoxin and umbelliferone attenuate cognitive dysfunction in a streptozotocin-induced rat model of sporadic Alzheimer’s disease: The role of JAK2/STAT3 and Nrf2/HO-1 signalling pathway modulation. Phytotherapy Research. 2020 Sep 1;34(9):2351–65.

Maciąg M, Michalak A, Skalicka-Wozniak K, Zykubek M, Ciszewski A, Budzynska B. Zebrafish and mouse models for anxiety evaluation – A comparative study with xanthotoxin as a model compound. Brain Res Bull. 2020 Dec 1; 165:139–45.

Kumar Ratha K, Hazra J. Pharmacognostical profiling on the root of Rauwolfia Serpentina. Article in International Journal of Pharmacognosy and Phytochemical Research [Internet]. 2014;6(3):612–6. Available from: https://www.researchgate.net/publication/283475323

Shimada T, Yamagata K. Pentylenetetrazol-induced kindling mouse model. Journal of Visualized Experiments. 2018 Jun 12;2018(136).

Ma L, Gu R, Tang L, Chen ZE, Di R, Long C. Important poisonous plants in Tibetan ethnomedicine. Toxins (Basel). 2015 Jan 8;7(1):138–55.

Singhapricha T, Pomerleau AC. A Case of Strychnine Poisoning from a Southeast Asian Herbal Remedy. Journal of Emergency Medicine. 2017 Apr 1;52(4):493–5.

Ochoa JG, Kilgo WA. The Role of Benzodiazepines in the Treatment of Epilepsy. Vol. 18, Current Treatment Options in Neurology. Current Science Inc.; 2016. p. 1–11.